A Biotech Bet on Dogecoin: Mining Rigs, Meme Power, and a 22% Monthly Surge

Nasdaq-listed Shuttle Pharmaceutical Holdings acquires United Dogecoin, plans 3,000 mining rigs as DOGE rallies 22.4% in 30 days, adding crypto to its balance sheet.

The notion of a pharmaceutical company pivoting into cryptocurrency mining might raise eyebrows, but for Shuttle Pharmaceutical Holdings, the logic is straightforward. The Nasdaq-listed biotech firm from Maryland has completed its acquisition of United Dogecoin, a deal backed by an $11 million private investment. The subsidiary will now operate as a mining arm, with plans to deploy up to 3,000 ElphaPex mining rigs within 60 days—targeting roughly 1.5% of global Dogecoin mining capacity. DOGE holdings will be added directly to the company’s balance sheet.

The move comes as Dogecoin posts the strongest 30-day performance among major digital assets, gaining 22.4% to trade at $0.11. That puts it ahead of Bitcoin’s 19.1% and Ethereum’s 15.0% over the same period, with Ethereum Classic and XRP trailing at 7.5% and 7.0%, respectively. The meme coin has shaken off its February low of $0.09 and climbed decisively above its 50-day moving average—a technically constructive signal, even if it remains roughly 61% below its 52-week high.

The rally is less about euphoria and more about recovery, reflecting a broader return of risk appetite among retail investors. Dogecoin has long served as a barometer for speculative sentiment, and the current data supports that reading. On-chain activity shows a notable spike: on April 28, analytics services recorded 739 transactions each exceeding $100,000, the highest tally in six months. Wallets holding more than 100 million DOGE reported record balances, while futures open interest hit a year-to-date peak.

Yet the technical picture is mixed. The relative strength index has cooled to around 46, easing from overbought levels in prior weeks. The price sits well below the 200-day moving average of $0.13 but comfortably above the 50-day average of $0.10. The resistance zone between $0.11 and $0.12 remains the critical hurdle—one that will test whether the recent accumulation by institutional addresses can be sustained.

Shuttle’s entry adds a new dimension to that equation. Ryan Trasolini steps in as co-CEO alongside Christopher Cooper, while CFO Yuying Liang remains in place. The success of the mining venture depends on whether the rigs come online as planned and whether additional institutional buyers follow suit. For now, Dogecoin’s price action remains a tug-of-war between technical constraints and rising on-chain momentum.

The broader crypto market shows similar tension. All five top assets posted positive monthly returns, yet each trades well below its 52-week peak. The divergence is telling: Dogecoin and Bitcoin delivered double-digit gains, while Ethereum Classic and XRP settled for single-digit advances. Capital is flowing toward the most liquid and narratively compelling names—a pattern typical of early recovery phases. Whether this turns into a sustained uptrend hinges on macroeconomic conditions, regulatory developments, and institutional allocation decisions.

For Dogecoin, the narrative is no longer purely about meme power. A biotech firm betting on mining infrastructure, record whale activity, and a cooling RSI all point to a market in transition. The next move will depend on whether the price can break through resistance—and whether the momentum behind the rigs matches the momentum behind the rally.